本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kymera Therapeutics, Inc.

116.58
+3.433.03%
成交量:27.18萬
成交額:3,149.23萬
市值:96.93億
市盈率:-36.29
高:116.97
開:113.06
低:112.88
收:113.15
52周最高:130.05
52周最低:47.86
股本:8,315.06萬
流通股本:6,487.46萬
量比:0.58
換手率:0.42%
股息:- -
股息率:- -
每股收益(TTM):-3.2122
每股收益(LYR):-3.6900
淨資產收益率:-24.15%
總資產收益率:-15.59%
市淨率:6.42
市盈率(LYR):-31.59

資料載入中...

2026/03/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

重要事件披露

Form 8-K - Current report
2025/12/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities